XML 28 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1Close
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net earnings/(loss) $ 619 $ 328
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation and amortization 524 516
Impairments and (gain)/loss on disposal of assets, net 622 883
Share-based compensation 88 69
Provision for bad debts 59 79
Change in operating assets and liabilities, net of effects from acquisitions and divestitures:    
Increase in trade receivables (262) (510)
Increase in inventories (1,371) (1,012)
Increase in accounts payable 2,276 2,473
Other accrued liabilities and operating items, net (870) (845)
Net cash provided by operating activities 1,685 1,981 Close
Cash flows from investing activities:    
Acquisition of subsidiaries, net of cash acquired 1,192 10
Proceeds from divestitures, net of cash sold 9 0
Additions to property and equipment (318) (264)
Proceeds from disposal of property and equipment 10 2
Purchases of investments (3) (6)
Proceeds from investments 1 1
Proceeds from net investment hedge terminations 28 29
Purchases of short-term time deposits (550) 0
Net cash used in investing activities (2,015) (248) Close
Cash flows from financing activities:    
Proceeds from long-term obligations, net of issuance costs 1,139 0
Reduction of long-term obligations (23) (571)
Net tax proceeds from share-based compensation 23 11
Dividends on common shares (377) (399)
Purchase of treasury shares (750) (1,500)
Net cash provided by/(used in) financing activities 12 (2,459) Close
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations (7) (1) Close
Net decrease in cash and equivalents (325) (727) Close
Cash and equivalents at beginning of period 4,043 4,717
Cash and equivalents at end of period $ 3,718 $ 3,990